NCT07553520 Dietary Cysteine and Methionine Deprivation (CMD) in Glioma Patients Status WITHDRAWN Phase NA
NCT07416188 Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma Status RECRUITING Phase PHASE1/PHASE2
NCT06991101 Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma Status RECRUITING Phase PHASE2
NCT06814496 Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06806228 Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status) Status SUSPENDED Phase PHASE1
NCT06585527 Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma Status RECRUITING Phase PHASE1
NCT06562621 Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT06533163 Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial Status RECRUITING Phase NA
NCT06496971 A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients Status RECRUITING Phase PHASE3
NCT06466031 Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO] Status RECRUITING Phase NA
NCT06451042 FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT) Status COMPLETED Phase N/A
NCT06418113 Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma Status RECRUITING Phase PHASE1
NCT06356883 Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma Status RECRUITING Phase PHASE2
NCT06353360 TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma. Status RECRUITING Phase PHASE2
NCT06346821 Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data Status COMPLETED Phase N/A
NCT06333899 Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion Status RECRUITING Phase EARLY_PHASE1
NCT06329570 Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM) Status RECRUITING Phase PHASE1/PHASE2
NCT06283927 The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) Status RECRUITING Phase N/A